Our Blog

Sign Up for Our Newsletter

Stay up on the latest enFuse^® technology, partnerships, events, and news by signing up to receive the once-monthly Enable Injections Newsletter direct to your inbox.

Enhancing the Patient and Nurse Experience in Large-Volume Subcutaneous Drug Delivery: The Shift to Comfort Ondrugdel-wearables-sep2024-enable-injections -1 Enable Injections

Enhancing the Patient and Nurse Experience in Large-Volume Subcutaneous Drug Delivery: The Shift to Comfort

Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories 2022-1-20-enableinjections-76933-purple Enable Injections

Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories

Matt-Huddleston-crop

Enable Injections Names Matthew Huddleston as Chief Commercial Officer

enfuse-5-25

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease

Enable Injections Expands Strategic Partnership with Roche Roche Expansion Release Apr 2024 Social Photo Apr2024 Proposed Compressed Enable Injections

Enable Injections Expands Strategic Partnership with Roche

Greg Etter Joins Enable Injections as VP, Engineering and Automation Greg Etter Enable Injections

Greg Etter Joins Enable Injections as VP, Engineering and Automation

Enable Injections Building

Enable Injections Announces Plans to Expand Manufacturing Facilities and Corporate Headquarters

Enable Injections Appoints David Kroekel as Chief Operating Officer Dave Kroekel Square Enable Injections

Enable Injections Appoints David Kroekel as Chief Operating Officer

Beyond the Point: Navigating the Impact of Needles on Pain, Anxiety, and the Patient Experience Feature Image Enable Injections

Beyond the Point: Navigating the Impact of Needles on Pain, Anxiety, and the Patient Experience

Enable Injections Enhances Board with Addition of Vickie Capps

The Call for Freedom – A Patient’s Perspective on Today’s Drug Delivery Systems Rebecca Holding Enfuse With Approval Statement Enable Injections

The Call for Freedom – A Patient’s Perspective on Today’s Drug Delivery Systems

2022_10_25_Empaveli_112486-Websize-Grey (1)

Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval

A New Frontier: Self-Administration of Lyophilized, Large-Volume Subcutaneous Biologics Sep 2023 Odd Website Feature Image Enable Injections

A New Frontier: Self-Administration of Lyophilized, Large-Volume Subcutaneous Biologics

Careers blog promo photo

Introducing Enable Injections’ New Careers Site!

partnership announcement Enable Injections

Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections

Allison Mack, Medical Education Lead

Sustainability Improvements in Drug Delivery with Allison Mack

website-feature-image-ODD-Feb-23

Reduce Pharma Development Time: Large-Volume Subcutaneous Delivery with the enFuse

Dave-Kroekel

Dave Kroekel Promoted to Senior Vice President, Product Development & Operations

enFuse-waste-photo-graphic

Sustainability Improvements in Drug Delivery: A Waste Comparison of IV vs. enFuse Large-Volume On-Body Delivery System

Russ-wordpress-feature-image

The Real Role of Regulatory Affairs

Nigel-Sheail-photo

Enable Injections Enhances Board with Addition of Nigel Sheail

2022_1_20_EnableInjections_76039-WEB-Blue-2

Enable Injections Commits to Cincinnati Growth with Increased Jobs

feature-clinical-benefits

Thinking Clinically: Potential Benefits with the enFuse

ODD-feature-image-screenshot

Flexible Care – Enable Wearable Delivery

Enable Injections enFuse wearable delivery

enFuse Enables Flexibility for Pharma

Mehul-Desai-Enable-Injections-VP-Medical-Affairs

Mehul Desai Joins Enable Injections as VP, Medical Affairs

John-DeFord-Enable Injections-news-new-board-member

Enable Injections Enhances Board with Addition of John DeFord, Ph.D.

enFuse on body delivery

New Look, Same Mission – enFuse®

Enable Injections-enFuse-drug-delivery-innovation

Enable Injections Enhances Board with Addition of Three New Directors

subcutaneous wearable drug delivery technology

Large-Volume Wearable Drug Delivery Technology Is Clinically Proven

large-volume-enFuse-wearable-enable-injections

Large-Volume Subcutaneous Delivery Is Feasible

Large Volume Wearable Subcutaneous Delivery-Webinar

At-Home Drug Delivery of Large Molecule Medicines – The Future Is Now

Large-Volume Subcutaneous Delivery

Large-Volume Subcutaneous Delivery

Enable Injections-enFuse-drug-delivery-innovation

Sanofi announces partnership with Enable Injections, Inc. on subcutaneous delivery for Sarclisa®

Russell Pagano Joins Enable Injections as VP, Regulatory Affairs

Reducing treatment burden on nurses

Reducing the Treatment Burden on Nurses

Enable Injections-enFuse-drug-delivery-innovation

Enable Injections Announces $215 Million Financing

Enable-Injections-Superpower

What Is Enable Injections’ Superpower?

Improving Patient Access

Getting Care to Patients – A New Paradigm

Enable Injections Modular Scalable Manufacturing

Enable Manufacturing Excellence: State-of-the-Art Modular Scalable Manufacturing

Drug Delivery: What Do Patients Want?

Drug Delivery: What Do Patients and Providers Want?

Getting Care to Patients

Reimagining Patient Access to Treatment

Rethinking Drug Delivery

Rethinking Drug Delivery: Innovation to Improve Patient Access to Care

Holiday Celebration 2019, Fretboard

Enable Injections: Our Story and Team Culture

Getting Care to Patients

Delaying Therapy or Risking Exposure: A Decision No One Should Have to Make

The New Patient-Centricity

The New Patient-Centricity

Enable Injections enFuse

Letter from Mike Hooven, CEO, Enable Injections

Enable Injections CEO Mike Hooven with enFuse

New Press on enFuse®

enFuse Vial Transfer System

New Utility Patent and enFuse® Vial Transfer System Technology

Forbes-article-Enable Injections SAP

enFuse® Featured in Forbes: This Pharma Startup Could Transform How Chronic Diseases Are Treated

Enable Injections enFuse 25-mL on-body infusor

Injection Devices: Wearables, Connectivity & Patient-Centric Designs Empower Self-Administration

OnDrugDelivery article Sept 2019 - Enable Injections

Key Challenges in Successful Wearable Drug Delivery and Patient Self-Administration

The Need for Advanced Delivery Reconstitution Systems

The Need for Advanced Delivery Reconstitution Systems

Scaling for Success: Why Enable Injections Is the Earliest-Stage Adopter of SAP

Scaling for Success: Why Enable Injections Is the Earliest-Stage Adopter of SAP

Combination Products: Success Is All about the Partnerships

Combination Products: Success Is All about the Partnerships

Enable enFuse and Autonomous Manufacturing

Autonomous Manufacturing for the Innovative enFuse On-Body Infusor

drug delivery device design and human factors

The Human Element in Drug Delivery Device Design

injection science blog post - enFuse On-Body Infusor - Enable Injections

Patient Tolerability with High-Viscosity, Large-Volume Subcutaneous Infusions

Advantages of Subcutaneous Administration: FDA Approvals by Route of Administration

Advantages of Subcutaneous Drug Delivery